Paper11429545
Lipid mediator class switching during acute inflammation: signals in resolution.
Levy BD and 4 others. Nat Immunol, 2001. Cited by 1,158 papers, by iCite.
Cite this record
ConductScience Library. Lipid mediator class switching during acute inflammation: signals in resolution. Papers, record 11429545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11429545
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dinoprostone | Major topic |
| Hydroxyeicosatetraenoic Acids | Major topic |
| Leukotriene B4 | Major topic |
| Lipoxins | Major topic |
| Neutrophils | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| Arachidonate 15-Lipoxygenase | |
| Base Sequence | |
| DNA, Complementary | |
| Humans | |
| Lipid Metabolism | |
| Lipids | |
| Male | |
| Mice | |
| Mice, Inbred BALB C | |
| Molecular Sequence Data | |
| Molecular Structure | |
| Pleural Effusion | |
| RNA, Messenger |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01-DE13499 | NIDCR NIH HHS | United States | P01DE013499 | PubMed and NIH | NIH RePORTER |
| K08-HL03788 | NHLBI NIH HHS | United States | K08HL003788 | PubMed and NIH | NIH RePORTER |
| F32-AI10389 | NIAID NIH HHS | United States | F32AI010389 | PubMed and NIH | NIH RePORTER |
| GM-38765 | NIGMS NIH HHS | United States | R01GM038765 | PubMed and NIH | NIH RePORTER |
| DK50305 | NIDDK NIH HHS | United States | P01DK050305 | PubMed and NIH | NIH RePORTER |
| K01 DK060583 | NIDDK NIH HHS | United States | K01DK060583 | PubMed and NIH | NIH RePORTER |
| R29GM038765 | NIH | NIH RePORTER | |||
| R37GM038765 | NIH | NIH RePORTER |
Trials2
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04444102 | The Acute Impact of Yoga-based Stretching on Inflammation and Its Resolution | Results | ClinicalTrials.gov | |
| NCT07237113 | Muscle Recovery After Omega-3 Supplementation | Results | ClinicalTrials.gov |
Cited by671
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,158 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978558 | Decanoic acid reduces extracellular prostaglandin accumulation, inhibits MRP4 transport, and enhances low-dose dexamethasone effects in IL-1β-stimulated human osteoarthritis synoviocytes. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42978558 | PubMed |
| 42909166 | Long COVID is associated with lipoxygenase-catalyzed metabolism of essential polyunsaturated fatty acids. | iScience | 2026 | https://conductscience.org/library/papers/42909166 | PubMed |
| 42889383 | Specialized pro-resolving mediators and cancer: news and promises from the other side of the moon. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42889383 | PubMed |
| 42848422 | Transcriptional regulation and function of GPR18 in macrophage subtype specification. | Proc Natl Acad Sci U S A | 2026 | https://conductscience.org/library/papers/42848422 | PubMed |
| 42797224 | Targeted Delivery of Specialized Pro-Resolving Mediators (SPMs) for Improved Treatments of Inflammatory Diseases and Cancer. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42797224 | PubMed |
| 42769565 | Failed resolution as a mechanistic basis of difficult-to-treat rheumatoid arthritis: stromal-myeloid crosstalk in the synovium and emerging resolution-restoring therapies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42769565 | PubMed |
| 42765007 | Tocotrienol metabolites redirect lipid mediator production in innate immune cells towards inflammation resolution. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42765007 | PubMed |
| 42668574 | BOLD-100 treatment induces systemic lipid crosstalk in metastatic colorectal carcinoma patients in a combination treatment with FOLFOX. | iScience | 2026 | https://conductscience.org/library/papers/42668574 | PubMed |
| 42588665 | Live Biotherapeutic Zowell Reprograms Microbiota-Lipid Crosstalk to Enhance Cisplatin Efficacy in Lung Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42588665 | PubMed |
| 42588091 | Lacticaseibacillus paracasei LP36 Alleviates Lipopolysaccharide-Induced Depression-like Behavior in Mice: A Serum Metabolomics Study. | Nutrients | 2026 | https://conductscience.org/library/papers/42588091 | PubMed |
| 42572568 | Sex-dependent bioactive lipid mediator profiles in multiple sclerosis. | Mult Scler J Exp Transl Clin | 2026 | https://conductscience.org/library/papers/42572568 | PubMed |
| 42488659 | Eosinophils as immunoregulatory players in allergic rhinitis: beyond cytotoxicity. | Front Immunol | 2026 | https://conductscience.org/library/papers/42488659 | PubMed |
| 42375359 | CURE: a phase-based therapeutic framework for chronic inflammation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42375359 | PubMed |
| 42286262 | Fibroadipogenic progenitor-secreted prostaglandin E2 coordinates stem cell fate via autocrine and paracrine crosstalk in healthy and dystrophic muscle. | Cell Death Differ | 2026 | https://conductscience.org/library/papers/42286262 | PubMed |
| 42254015 | Neutrophil immunometabolism in ACLF and sepsis: mechanisms, dysfunction, and therapeutic opportunities. | Front Immunol | 2026 | https://conductscience.org/library/papers/42254015 | PubMed |
| 42183275 | Neutrophil efferocytosis in chronic inflammatory gastrointestinal diseases: mechanistic insights and therapeutic potential. | Front Immunol | 2026 | https://conductscience.org/library/papers/42183275 | PubMed |
| 42143067 | Social isolation of aged mice drives dramatic release of inflammatory lipoxygenase-derived oxylipins. | NPJ Aging | 2026 | https://conductscience.org/library/papers/42143067 | PubMed |
| 42100056 | Pediatric Critical Illness, Immunometabolism and Cardiovascular Risk: A Narrative Review. | Minerva Pediatr (Torino) | 2026 | https://conductscience.org/library/papers/42100056 | PubMed |
| 42087046 | Association of preoperative corticosteroids with persistent opioid requirements following total knee arthroplasty: an exploratory population-based cohort study. | Can J Anaesth | 2026 | https://conductscience.org/library/papers/42087046 | PubMed |
| 41993620 | Context-dependent Activities of Mitrephorone Link Lipid Redirection, Anti-inflammatory Action, and Ferroptosis Control to Hepatocyte Protection. | Theranostics | 2026 | https://conductscience.org/library/papers/41993620 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALOX15 | 246 | PubTator's text mining | https://conductscience.org/library/genes/246 | NCBI Gene |
| ALOX5 | 240 | PubTator's text mining | https://conductscience.org/library/genes/240 | NCBI Gene |
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11429545
GET https://conductscience.org/api/papers/v1/11429545/cited_by?page=2